Inovio Pharmaceuticals
INO
INO
227 hedge funds and large institutions have $581M invested in Inovio Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 72 increasing their positions, 56 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
16% less call options, than puts
Call options by funds: $45.5M | Put options by funds: $54.1M
20% less capital invested
Capital invested by funds: $723M → $581M (-$142M)
Holders
227
Holding in Top 10
1
Calls
$45.5M
Puts
$54.1M
Top Buyers
| 1 | +$7.9M | |
| 2 | +$5.31M | |
| 3 | +$4.92M | |
| 4 |
BlackRock
New York
|
+$4.7M |
| 5 |
Man Group
London,
United Kingdom
|
+$4.56M |
Top Sellers
| 1 | -$8.93M | |
| 2 | -$8.73M | |
| 3 | -$5.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.39M |
| 5 |
Goldman Sachs
New York
|
-$3.24M |